HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Koehler Selected Research

Achalasia Addisonianism Alacrimia syndrome

2/2016Low bone mineral density for age/osteoporosis in triple A syndrome-an overlooked symptom of unexplained etiology.
2/2013Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress.
8/2010Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome.
4/2006Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation.
11/2004The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Koehler Research Topics

Disease

5Achalasia Addisonianism Alacrimia syndrome
02/2016 - 11/2004
3Alacrima
02/2016 - 11/2004
3Esophageal Achalasia (Megaesophagus)
02/2016 - 11/2004
1Prediabetic State (Prediabetes)
06/2018
1Weight Loss (Weight Reduction)
01/2017
1Body Weight (Weight, Body)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
03/2016
1Neoplasms (Cancer)
03/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2016
1Metabolic Bone Diseases (Osteopenia)
02/2016
1Osteoporosis
02/2016
1Malnutrition (Nutritional Deficiencies)
02/2016
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
08/2010
1Fatty Liver
08/2010
1Polyuria
01/2009
1Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2009
1Dehydration (Water Stress)
01/2009
1Rare Diseases (Rare Disease)
01/2009
1Polydipsia
01/2009
1Muscular Diseases (Myopathy)
01/2006
1Muscular Dystrophies (Muscular Dystrophy)
01/2006
1Myotonia
01/2006
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
01/2006
1Granuloma
10/2003
1Abscess
10/2003
1Wilms Tumor (Wilm's Tumor)
05/2000

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
02/2016 - 11/2004
2Adrenocorticotropic Hormone (ACTH)FDA Link
08/2010 - 11/2004
1Environmental Pollutants (Pollutants, Environmental)IBA
06/2018
1Hormones (Hormone)IBA
01/2017
1pazopanibFDA Link
03/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2016
1DNA (Deoxyribonucleic Acid)IBA
03/2016
1Heme (Haem)IBA
03/2016
1Biomarkers (Surrogate Marker)IBA
03/2016
1GlucocorticoidsIBA
02/2016
1AndrogensIBA
02/2016
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2016
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
02/2013
1Insulin (Novolin)FDA Link
08/2010
1Nonesterified Fatty Acids (NEFA)IBA
08/2010
1Glucagon (Glukagon)FDA Link
08/2010
1Glucose (Dextrose)FDA LinkGeneric
08/2010
1Glycerol (Glycerine)FDA LinkGeneric
08/2010
1Arginine Vasopressin (Argipressin)IBA
01/2009
1Genetic Markers (Genetic Marker)IBA
01/2006
1VaccinesIBA
10/2003
1AntibodiesIBA
10/2003
1Messenger RNA (mRNA)IBA
05/2000
1Transcription Factors (Transcription Factor)IBA
05/2000

Therapy/Procedure

1Caloric Restriction
01/2017
1Therapeutics
02/2016